Al Ain, UAE
Imperial College of London Diabetes Centre is a one-stop, state-of-the-art, out-patient facility that specialises in diabetes treatment, research, training and public health awareness.
AE7 acted as the architect of record for Phase II built in Al Ain as an extension of the ICLDC’s services already provided in Abu Dhabi. Phase II provides world-class standards of care to patients in Al Ain and the surrounding region.
The launch of this new facility followed the establishment of the first Imperial College London Diabetes Centre in Abu Dhabi in 2006 and is an extension of the partnership agreement between Mubadala Investment Company and Imperial College London, a science-based institution that is consistently rated as one of the world’s best universities.